A Quote, Financials, Valuation and Earnings

Azenta has a net margin of 12.89% compared to Agilent Technologies's net margin of -28.21%. Agilent Technologies's return on equity of 19.32% beat Azenta's return on equity of -3.48%.

Agilent Technologies has a consensus price target of $136.83, signalling upside risk potential of 20.63%. On the other hand Azenta has an analysts' consensus of $33.75 which suggests that it could grow by 5.21%. Given that Agilent Technologies has higher upside potential than Azenta, analysts believe Agilent Technologies is more attractive than Azenta.

Agilent Technologies has a beta of 1.230, which suggesting that the stock is 22.975% more volatile than S&P 500. In comparison Azenta has a beta of 1.637, suggesting its more volatile than the S&P 500 by 63.674%.

Agilent Technologies has a quarterly dividend of $0.25 per share corresponding to a yield of 0.86%. Azenta offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilent Technologies pays 21.26% of its earnings as a dividend. Azenta pays out -- of its earnings as a dividend. Agilent Technologies's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Agilent Technologies quarterly revenues are $1.7B, which are larger than Azenta quarterly revenues of $143.4M. Agilent Technologies's net income of $215M is higher than Azenta's net income of -$40.5M. Notably, Agilent Technologies's price-to-earnings ratio is 28.01x while Azenta's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies is 4.91x versus 2.43x for Azenta. Usually stocks with elevated PS ratios are considered overvalued.

Bruker has a net margin of 12.89% compared to Agilent Technologies's net margin of 2.17%. Agilent Technologies's return on equity of 19.32% beat Bruker's return on equity of 4.53%.

Agilent Technologies has a consensus price target of $136.83, signalling upside risk potential of 20.63%. On the other hand Bruker has an analysts' consensus of $54.11 which suggests that it could grow by 30.26%. Given that Bruker has higher upside potential than Agilent Technologies, analysts believe Bruker is more attractive than Agilent Technologies.

Agilent Technologies has a beta of 1.230, which suggesting that the stock is 22.975% more volatile than S&P 500. In comparison Bruker has a beta of 1.181, suggesting its more volatile than the S&P 500 by 18.13%.

Agilent Technologies has a quarterly dividend of $0.25 per share corresponding to a yield of 0.86%. Bruker offers a yield of 0.48% to investors and pays a quarterly dividend of $0.05 per share. Agilent Technologies pays 21.26% of its earnings as a dividend. Bruker pays out 26.7% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Agilent Technologies quarterly revenues are $1.7B, which are larger than Bruker quarterly revenues of $801.4M. Agilent Technologies's net income of $215M is higher than Bruker's net income of $17.4M. Notably, Agilent Technologies's price-to-earnings ratio is 28.01x while Bruker's PE ratio is 79.93x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies is 4.91x versus 1.82x for Bruker. Usually stocks with elevated PS ratios are considered overvalued.

Harvard Bioscience has a net margin of 12.89% compared to Agilent Technologies's net margin of -231.19%. Agilent Technologies's return on equity of 19.32% beat Harvard Bioscience's return on equity of -103.83%.

Agilent Technologies has a consensus price target of $136.83, signalling upside risk potential of 20.63%. On the other hand Harvard Bioscience has an analysts' consensus of $3.00 which suggests that it could grow by 640.74%. Given that Harvard Bioscience has higher upside potential than Agilent Technologies, analysts believe Harvard Bioscience is more attractive than Agilent Technologies.

Agilent Technologies has a beta of 1.230, which suggesting that the stock is 22.975% more volatile than S&P 500. In comparison Harvard Bioscience has a beta of 1.524, suggesting its more volatile than the S&P 500 by 52.373%.

Agilent Technologies has a quarterly dividend of $0.25 per share corresponding to a yield of 0.86%. Harvard Bioscience offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilent Technologies pays 21.26% of its earnings as a dividend. Harvard Bioscience pays out -- of its earnings as a dividend. Agilent Technologies's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Agilent Technologies quarterly revenues are $1.7B, which are larger than Harvard Bioscience quarterly revenues of $21.8M. Agilent Technologies's net income of $215M is higher than Harvard Bioscience's net income of -$50.3M. Notably, Agilent Technologies's price-to-earnings ratio is 28.01x while Harvard Bioscience's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies is 4.91x versus 0.19x for Harvard Bioscience. Usually stocks with elevated PS ratios are considered overvalued.

Revvity has a net margin of 12.89% compared to Agilent Technologies's net margin of 6.35%. Agilent Technologies's return on equity of 19.32% beat Revvity's return on equity of 3.68%.

Agilent Technologies has a consensus price target of $136.83, signalling upside risk potential of 20.63%. On the other hand Revvity has an analysts' consensus of $124.12 which suggests that it could grow by 29.43%. Given that Revvity has higher upside potential than Agilent Technologies, analysts believe Revvity is more attractive than Agilent Technologies.

Agilent Technologies has a beta of 1.230, which suggesting that the stock is 22.975% more volatile than S&P 500. In comparison Revvity has a beta of 0.977, suggesting its less volatile than the S&P 500 by 2.331%.

Agilent Technologies has a quarterly dividend of $0.25 per share corresponding to a yield of 0.86%. Revvity offers a yield of 0.29% to investors and pays a quarterly dividend of $0.07 per share. Agilent Technologies pays 21.26% of its earnings as a dividend. Revvity pays out 12.74% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Agilent Technologies quarterly revenues are $1.7B, which are larger than Revvity quarterly revenues of $664.8M. Agilent Technologies's net income of $215M is higher than Revvity's net income of $42.2M. Notably, Agilent Technologies's price-to-earnings ratio is 28.01x while Revvity's PE ratio is 40.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies is 4.91x versus 4.23x for Revvity. Usually stocks with elevated PS ratios are considered overvalued.